Trend

Last Previous Currency Date Chng
1,323.03 1,321.55 USD 26/11/19 +0.11

Terms

Isin LU0108459040
Contract Type Sicav
Currency USD
Class C
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotechnology Net TR Index
Start Date 00/04/06
Advisor Name Rudi Van den Eynde
Fund Asset Under Management 483,3848  at 26/10/30

Performance

Cumulatives
1 month +4.59
Ytd +20.31
1 year +20.95
3 years +84.38
5 years +72.48
Yearly
10/31/2025 +22.51
10/31/2024 +9.08
10/31/2023 +3.44
10/31/2022 +4.61
10/31/2021 +5.46
Rating
Score
65.3622

Company

Candriam
19-21, ROUTE D'ARLON 8009 - Strassen
Tel. +352-27975130

Costs

Entrance (ACP) Min: 3,5000 - Max: 3,5000
Management 1.6
Reimbursement 0%
Administrative 0,4%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial 0,0000 USD
Integrative 0,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 0,0000

Costs

Entrance (ACP) Min: 3,5000 - Max: 3,5000
Management 1.6
Reimbursement 0%
Administrative 0,4%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day -0.11
1 week -2.76
1 month +4.59
3 months -7.58
6 months +18.53
From the beginning of the year +20.31
1 year +20.95
2 years +47.72
3 years +84.38
4 years +61.87
5 years +72.48
Yearly
10/31/2025 +22.51
10/31/2024 +9.08
10/31/2023 +3.44
10/31/2022 +4.61
10/31/2021 +5.46


Rating
Rating Rating Rating Rating
Score
65.3622

Efficiency Indicators

Sharpe 1 year 1.2066
Benchmark 1 year N.Av.
Sharpe 3 years 0.9608
Benchmark 3 years N.Av.
Sharpe 5 years 0.5234
Benchmark 5 years N.Av.
Sortino 1 year 3.6591
Benchmark 1 year N.Av.
Sortino 3 years 1.8597
Benchmark 3 years N.Av.
Sortino 5 years 0.9972
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +18.95
3 years +19.11
5 years +17.73
Negative Volatility
1 year +6.82
3 years +9.68
5 years +10.17

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/10/30

Relative

Sharpe 0.9608
Sortino 1.8597
Bull Market +2.34
Bear Market -3.81
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 18,269 3 years 16,079 5 years 14,443
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,269
617
  
+28.27
3 years 16,079
802
  
+88.63
5 years 14,443
998
  
+77.27
Performance
617 +28.27 802 +88.63 998 +77.27
Total Volatility
1 year 18,269
20,157
  
+18.95
3 years 16,079
18,689
  
+19.11
5 years 14,443
15,629
  
+17.73
Total Volatility
20,157 +18.95 18,689 +19.11 15,629 +17.73
Negative Volatility
1 year 18,269
13,923
  
+6.82
3 years 16,079
17,215
  
+9.68
5 years 14,443
13,737
  
+10.17
Negative Volatility
13,923 +6.82 17,215 +9.68 13,737 +10.17
Sharpe Index
1 year 18,269
2,169
  
+1.21
3 years 16,079
4,312
  
+0.96
5 years 14,443
2,129
  
+0.52
Sharpe Index
2,169 +1.21 4,312 +0.96 2,129 +0.52
Sortino Index
1 year 18,269
1,106
  
+3.66
3 years 16,079
1,670
  
+1.86
5 years 14,443
1,292
  
+1.00
Sortino Index
1,106 +3.66 1,670 +1.86 2,129 +1.00

By Category

  1 year 18,269 3 years 16,079 5 years 14,443
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,269
12
  
+28.27
3 years 16,079
15
  
+88.63
5 years 14,443
7
  
+77.27
Performance
12 +28.27 15 +88.63 7 +77.27
Total Volatility
1 year 18,269
95
  
+18.95
3 years 16,079
90
  
+19.11
5 years 14,443
84
  
+17.73
Total Volatility
95 +18.95 90 +19.11 84 +17.73
Negative Volatility
1 year 18,269
20
  
+6.82
3 years 16,079
71
  
+9.68
5 years 14,443
56
  
+10.17
Negative Volatility
20 +6.82 71 +9.68 56 +10.17
Sharpe Index
1 year 18,269
24
  
+1.21
3 years 16,079
10
  
+0.96
5 years 14,443
6
  
+0.52
Sharpe Index
24 +1.21 10 +0.96 6 +0.52
Sortino Index
1 year 18,269
24
  
+3.66
3 years 16,079
16
  
+1.86
5 years 14,443
7
  
+1.00
Sortino Index
24 +3.66 16 +1.86 7 +1.00

Foreign Funds - Candriam Eq. L Biotechnology C $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.